HRT Side Effects: Common, Serious and How Long They Last
Breast tenderness, spotting, bloating and mood changes are the most common HRT side effects. Learn which settle, which need a dose change and which are serious.

On this page
- What are the most common HRT side effects?
- How long do HRT side effects last?
- What are the risks of hormone replacement therapy?
- What the research says about HRT side effects
- Does HRT cause weight gain, and is HRT weight loss possible?
- HRT before and after: what to expect over 3 to 12 months
- Is testosterone part of HRT for menopause?
- How do you prepare for an HRT review appointment?
- When to see a doctor
- Regional notes
- Frequently asked questions
- The bottom line
HRT side effects are usually mild and most often start in the first few months. Breast tenderness, irregular bleeding, bloating, headaches and mood changes are the most common, and many settle within about three months. Serious risks, such as a small rise in breast cancer risk with combined HRT, depend on age, hormone type, route and personal history.
HRT side effects: the unwanted effects of menopausal hormone therapy, which replaces estrogen and, in most women with a uterus, adds a progestogen to ease symptoms and protect the womb lining.
Key takeaways
- According to NHS menopause guidance, early side effects of hormone therapy such as breast tenderness, spotting, bloating and headaches are common, and many settle within about three months.
- If an early side effect does not settle, NICE guideline NG23 supports reviewing the treatment, which can mean changing the dose, the route or the type of progestogen.
- The Menopause Society's 2022 position statement says that for healthy women with bothersome symptoms who are under 60 or within 10 years of menopause, benefits generally outweigh risks.
- In the Women's Health Initiative trial, per 10,000 women-years on estrogen plus progestin, there were 8 more invasive breast cancers and 8 more pulmonary embolisms than on placebo (Rossouw et al., JAMA 2002).
- Oral estrogen carries a higher blood-clot risk than transdermal estrogen, according to The Menopause Society, so the route you choose matters for this specific risk.
- Large trials have not shown that HRT causes significant weight gain on average, and HRT is not a weight-loss treatment.
What are the most common HRT side effects?
Most people who start hormone therapy notice some HRT menopause side effects in the first weeks or months. Side effects tend to be mild and temporary, and they often reflect the body adjusting to a new level of hormones. Some come from estrogen, others from the progestogen added to protect the lining of the womb, and some depend on how the hormone is delivered. Knowing which group a symptom belongs to helps you decide whether it is likely to pass or needs a change in treatment.
Common early effects include breast tenderness, bloating, headaches, spotting or irregular bleeding, and mood changes such as irritability or low mood. Nausea and leg cramps are reported less often. Breast tenderness and bloating are among the most frequent early complaints, and they usually ease as the body settles into the regimen. Your clinician can tell you how common each effect is for the regimen you are considering, because the pattern differs between tablets, patches, gels and combined treatments.
To sort out which symptoms belong to the menopause transition itself, the perimenopause symptoms guide lists them, and the menopause hub links to the rest of the series. Some of what you feel at the start may belong to the menopause rather than the treatment. Sleep disturbance, mood shifts and headaches can all occur during the transition, so a clear before-and-after record helps separate the two.
A symptom log such as Shebalance lets you rate bloating, mood and sleep on the same 0 to 5 scale every day. Over two or three weeks, that record shows whether a side effect is easing, staying the same or getting worse, which is far more useful to your clinician than a memory of how the first week felt.

What are estrogen patch side effects?
Estrogen patches and gels are applied to the skin, and their side effects tend to be different from those of tablets. The most noticeable is skin irritation: redness, itching or a small rash where the patch sits. Changing the site each time, and letting the skin rest between applications, reduces this for many people. Some patches lose their grip in heat or after showering, which can cause a short gap in hormone delivery and a return of symptoms. Estrogen itself can still cause breast tenderness and headaches, so patches do not remove every early effect.
The NHS explains on its menopause page that treatment choices, including patches and gels, should be discussed with a clinician who knows your history. If a patch causes persistent skin reactions, the clinician can suggest a different patch, a gel or a tablet.
What are progesterone side effects?
Women with a uterus need a progestogen alongside estrogen, because estrogen alone can thicken the womb lining over time. Progestogens can cause their own side effects. Bloating, breast tenderness, mood changes such as irritability or tearfulness, and changes in sleep are the most often reported. The effects depend on the specific progestogen. Synthetic progestins are a different molecule from progesterone, and micronized progesterone, which is chemically identical to the hormone the body makes, is sometimes taken at bedtime because it can cause drowsiness. That helps some people sleep and bothers others.
In clinical practice, progestogen-related mood and bloating effects are a common reason to change the type of progestogen rather than stop treatment altogether. Because the progestogen is needed for womb protection in most cases, stopping it without advice is not a safe fix. Tell your clinician which pattern you notice, so they can choose a different progestogen or a different schedule.
Why does bleeding happen on HRT, and when is it a concern?
Irregular spotting or light bleeding is one of the most common early effects, especially in the first few months of a regimen that combines estrogen with a progestogen. It often settles as the body adjusts. A regimen that is designed to produce a monthly withdrawal bleed can also cause a bleed that feels unexpected if the timing shifts. Bleeding is not a reason to panic, but it is a reason to report it.
NICE guideline NG23 recommends that unscheduled bleeding on hormone therapy is assessed rather than ignored. Any bleeding that is heavier than usual, returns after a period of settling, or starts after you have been on a stable regimen for some time should be checked promptly. Record the date and amount, because a clinician will ask about it.
Why do headaches and breast tenderness happen?
Estrogen affects blood vessels and fluid balance, and it can cause breast tenderness in the early weeks. Headaches are also reported, and they may be linked to the hormone change itself or to the progestogen. Persistent or severe headaches, especially if they come with vision changes, weakness on one side or trouble speaking, need urgent assessment rather than a dose change. Mild, short-lived headaches and breast tenderness usually respond to waiting, a dose or route change, or simple measures such as a supportive bra and regular meals, which your clinician can help you choose.
How long do HRT side effects last?
Most early side effects are expected to ease over time. NHS guidance says that many settle within about three months of starting, and that a clinician can help if they do not. Three months is a useful checkpoint rather than a fixed rule, because some people feel a benefit within weeks and others take longer to find the right regimen.
Do early side effects settle after about three months?
For many people, yes. Breast tenderness, bloating and early headaches often fade as the body adjusts to a steady hormone level. Irregular bleeding also tends to become more predictable within a few months on a stable regimen. The pattern is not guaranteed, and it depends on the type, dose and route of the hormones. If a side effect is still bothersome after about three months, that is a clear reason to book a review rather than to wait longer.
The reason for the timeline is physiological. Hormone levels rise quickly after a new treatment starts, and the tissues that respond to them, such as the breast and the womb lining, take weeks to reach a new steady state. A side effect that appears in week one and is gone by week twelve is often a normal adjustment, while one that remains unchanged after several months may point to a dose, route or progestogen issue.
What if side effects do not settle?
Persistent side effects are a reason to adjust treatment, not to suffer through it or to stop without advice. NICE guideline NG23 supports individualized review, and options include a lower or higher dose, a different route such as a patch or gel, or a different progestogen. Sometimes the best change is a different schedule, so that the progestogen is taken in a way that causes fewer mood or bloating effects. A clinician may also consider whether a symptom has a different cause altogether, such as thyroid changes, anxiety or poor sleep. If hormones are not the right fit at all, our guide to non-hormonal hot-flash treatments compares the alternatives.
The table below compares routes, because the choice of route often changes which side effects are most likely.
| Route | How it is taken | Side-effect pattern to note |
|---|---|---|
| Oral estrogen tablet | Swallowed daily | Higher blood-clot risk than transdermal estrogen, according to The Menopause Society |
| Transdermal patch or gel | Applied to the skin on a set schedule | Skin redness or itching at the application site; lower clot risk than oral estrogen |
| Vaginal estrogen | Cream, ring or tablet placed in the vagina | Mostly local effects such as irritation or discharge; low absorption into the body at usual doses |
| Progestogen added to estrogen | Tablet, daily or cyclic, or an intrauterine system | Bloating, breast tenderness and mood changes; the type of progestogen matters |
Try it
Log bloating, breast tenderness, sleep and mood on the same 0 to 5 scale for three weeks, then bring the trend to your next visit so the decision about dose or route rests on data. Open Shebalance
What are the risks of hormone replacement therapy?
The risks of hormone replacement therapy are real, but they are not the same for every woman, and they depend on what is taken, how it is taken and when it is started. Understanding the difference between a small average risk and a large individual risk helps you weigh the trade-off. Looking at both the cons of HRT for women and the benefits of relieving hot flashes, sleep disruption and bone loss gives the fairest picture.
What are the cons of HRT for women?
The main drawbacks of women hormone replacement therapy are the side effects already described, plus a set of serious but uncommon risks. Common drawbacks include breast tenderness, bloating, irregular bleeding and the need for regular monitoring. The serious risks that receive the most attention are blood clots, stroke, heart disease and certain cancers. The size of each risk depends on the regimen, the woman's age, how long she has been menopausal and her health history. Many people find the honest answer is that the risks are small for some groups and more important for others, which is why an individual review matters.
Balanced reading also means recognizing the benefits. The Menopause Society's position statement states that hormone therapy is the most effective treatment for hot flashes and night sweats, and that it can also help with sleep and bone protection. The decision is about trade-offs, not about whether HRT is good or bad in general.
How does HRT affect blood clot risk?
The route of estrogen matters most for clot risk. Oral estrogen passes through the liver before it reaches the bloodstream, and it is associated with a higher risk of venous thromboembolism, meaning a deep vein clot or a clot in the lungs, than transdermal estrogen. The Menopause Society's 2022 position statement says that transdermal estrogen does not carry the same clot risk, and NICE guideline NG23 also distinguishes between routes when it discusses treatment choice. For people with a higher baseline clot risk, a transdermal route is often the preferred starting point.
Clot warning signs are urgent. Pain, swelling or warmth in one leg, sudden chest pain and sudden shortness of breath need emergency assessment. These are not side effects to wait out.
Does combined HRT raise breast cancer risk?
Combined HRT, meaning estrogen with a progestogen, is associated with a higher risk of breast cancer in the trial data. The best-known source is the Women's Health Initiative, or WHI, a large randomized trial. Its 2002 report (Rossouw et al., JAMA 2002) found that per 10,000 women-years on estrogen plus progestin compared with placebo, there were 8 more invasive breast cancers, along with 7 more coronary events, 8 more strokes and 8 more pulmonary embolisms. The average participant was 63 years old, so these figures describe older women, not women who start treatment near menopause.
The U.S. Food and Drug Administration announced on November 10, 2025 that it was removing boxed-warning references to cardiovascular disease, breast cancer and probable dementia from hormone therapy labels, and on February 12, 2026 it approved the first label changes for six products. The FDA's November 2025 announcement explains the reasoning, and its February 2026 labeling update describes the changes to individual products; both are on the FDA website. Our guide to whether HRT is safe covers the labeling change in more depth. A label change does not mean the risk disappeared, and it does not make the WHI data irrelevant; it changes how the numbers are presented to clinicians and patients.
Why does progestogen matter for the womb lining?
For women who have a uterus, estrogen alone increases the risk of endometrial cancer, which is cancer of the womb lining. This is why estrogen-alone products keep an endometrial cancer warning in their labeling, and why a progestogen is normally added for women who have not had a hysterectomy. The progestogen protects the lining. The Menopause Society's 2022 statement and the FDA labeling both reflect this principle. Women who have had a hysterectomy usually take estrogen alone, and the endometrial question does not apply in the same way.
What the research says about HRT side effects
The evidence on HRT side effects comes from several levels of study. The strongest evidence on serious outcomes is from large randomized trials, especially the WHI, which studied oral estrogen plus progestin and oral estrogen alone in women who were on average older than most people starting treatment today. Those trials gave clear answers about average risks in that population, and they shaped the cautious tone of early guidance.
More recent evidence includes observational studies, which follow women over long periods but cannot prove cause and effect, and reviews that combine these data with trial results. The Menopause Society's 2022 position statement draws on this full range and concludes that, for healthy women with bothersome symptoms who are under 60 or within 10 years of menopause, benefits generally outweigh risks. That conclusion depends on age and timing, which is why the same treatment can be a reasonable choice for one woman and a poorer fit for another.
Clinical guidelines from NICE and the International Menopause Society use similar principles. They emphasize individual assessment, the route of estrogen, and the importance of a progestogen for women with a uterus. The evidence on side effects such as mood and bloating is weaker than the evidence on serious outcomes, because these effects are harder to measure in trials and vary widely between people. Treat that as a limitation of the data, not a reason to dismiss them. A clinician who hears a consistent pattern of mood change will take it seriously even if the trial data are thin.
Where the evidence is mixed, it is fair to say so. The breast cancer findings from the WHI are clear for the population studied, but the absolute risk for a younger woman who starts within 10 years of menopause is different, and the data for that group are less certain. Your clinician can explain how the numbers apply to your age, your family history and the regimen you are considering.
Does HRT cause weight gain, and is HRT weight loss possible?
Randomized trials of hormone therapy have not shown that it causes significant weight gain on average. Many women do notice changes in weight and body shape during the menopause transition, and this is often linked to age, reduced activity, sleep disruption and changes in how fat is distributed around the body. Hormone therapy has not been shown to produce a meaningful average weight increase, although individual experiences vary and some people do gain weight during treatment for other reasons.
HRT is not a weight-loss treatment. It is prescribed to relieve menopausal symptoms and, in some cases, to help protect bone; it is not prescribed to prevent heart disease. It does not reduce body fat as a goal, and it should not be started for weight loss. If you want to manage weight during the menopause transition, the evidence points to regular physical activity, strength training, adequate protein and good sleep. A clinician can also review whether a weight change has another cause, such as thyroid disease or medication effects.
Our guide to menopause and weight gain explains the physiology of fat redistribution in more detail. The short answer for HRT is that it is a symptom and health treatment, and any weight change during treatment deserves a conversation rather than an assumption that the hormones are to blame.
HRT before and after: what to expect over 3 to 12 months
Most people want to know what HRT will feel like in practice. The timeline below describes a typical pattern, drawn from NHS guidance and from The Menopause Society's clinical framing. Individual timing varies, and the schedule is a guide for planning reviews, not a promise.
Start by recording a baseline before treatment begins. Note your hot flashes, sleep, mood, bleeding pattern and energy on a daily scale for two to three weeks. That baseline is what makes the "after" picture meaningful, because memory tends to smooth out bad days and make progress look either better or worse than it was.
| Time on treatment | What is often happening | What to note and discuss |
|---|---|---|
| Before starting | Symptoms are at their usual level; bleeding pattern is known | Baseline record of symptoms, sleep, mood and bleeding |
| Weeks 1 to 6 | Breast tenderness, bloating, headaches and spotting are most noticeable | Log daily; report anything that is severe or persistent |
| Months 2 to 3 | Many early side effects ease; hot flashes often reduce | Review at a follow-up if side effects still bother you |
| Months 3 to 6 | Bleeding pattern usually settles on a stable regimen; sleep and mood may improve if hot flashes ease | Check whether the dose, route or progestogen needs adjusting |
| Months 6 to 12 | Benefits and side effects are compared against your goals | Decide with your clinician whether to continue, adjust or stop |
The first six weeks are when the most noticeable changes happen, and they are also when people are most likely to stop treatment. Early side effects can feel discouraging, but many are temporary. Reporting them early is more useful than quietly giving up, because a dose or route change may solve the problem without losing the benefit.
Between months three and six, a clear pattern usually emerges. Hot flashes and night sweats often reduce, which can improve sleep. Bleeding becomes more predictable on most regimens. This is the stage where a trend record is especially useful, because it shows whether you are better overall, even if some days are still hard.
Between six and twelve months, the question shifts from "is this working?" to "is this the right long-term plan?" Bone protection is one of the reasons some women continue hormone therapy, because estrogen slows the bone loss that follows menopause. The Menopause Society's guidance is that the decision should be reviewed regularly, not assumed to be permanent or temporary. Our menopause and osteoporosis guide explains bone health in more detail.
Is testosterone part of HRT for menopause?
Many people ask about HRT menopause testosterone, because it is sometimes discussed alongside hormone therapy, especially for low sexual desire after menopause. The 2019 Global Consensus Position Statement on testosterone therapy for women, by Davis and colleagues, found that the only evidence-based indication is hypoactive sexual desire disorder in postmenopausal women. Testosterone can cause side effects that include acne, oily skin and unwanted hair growth, and the statement describes the need for careful monitoring. No testosterone product is FDA-approved for women in the United States. The FDA held a public meeting on testosterone use in menopausal women in September 2026, and the FDA's event page is the place to follow what comes next. Our article on testosterone for women in menopause explains the evidence in more depth.
How do you prepare for an HRT review appointment?
A review appointment is most productive when you arrive with a clear record and a short list of priorities. The steps below help you use the time well and make sure the important side effects are heard, weighed and acted on. The checklist works whether you are reviewing a current regimen or deciding whether to start.
- Bring a summary of the last four to twelve weeks, with the average severity of each symptom and each side effect, from a tracker or diary.
- Write down your bleeding pattern, including the date of any spotting, bleeding or unusual episode since starting.
- List every medicine, supplement and herbal product you take, with the dose and how often.
- Share your personal and family history of breast cancer, blood clots, heart disease, stroke, migraine and endometrial conditions.
- Name the one or two side effects that bother you most, and explain how they affect work, sleep or relationships.
- Ask which route, dose and type of progestogen the clinician recommends, and why, so you understand the trade-off.
- Ask what would prompt a change of plan, and when you should come back, so the next review has a clear purpose.
A tracker can make steps one and five much easier. Shebalance can produce a doctor-ready PDF report for an appointment, so the key patterns are visible without scrolling through daily entries. It is a starting point, not a substitute for your clinician's questions or examination.
When to see a doctor
Most HRT side effects are not dangerous, but some changes need prompt medical assessment rather than waiting for your next routine review. Contact a clinician quickly if you notice any of the signs below, and seek emergency care if symptoms are sudden or severe.
Get urgent care if you notice
- Vaginal bleeding that is heavier than usual, unexpected, or returns after a settled period.
- Pain, swelling or warmth in one leg, which can be a sign of a blood clot.
- Sudden chest pain, sudden shortness of breath or coughing up blood.
- A sudden severe headache, vision changes, weakness on one side or trouble speaking.
- A new lump in the breast, or a breast change that does not settle.
- Thoughts of suicide or self-harm. In the U.S., call or text 988; elsewhere, contact your local emergency number.
Regional notes
United States. The FDA regulates menopausal hormone therapy and publishes label changes, including the November 2025 announcement and the February 2026 labeling updates. The American College of Obstetricians and Gynecologists publishes patient FAQs on menopause through ACOG, and The Menopause Society sets clinical guidance. The National Institute on Aging describes treatment options on its menopause page.
United Kingdom. The NHS provides patient guidance through its menopause page, and NICE guideline NG23 is the main clinical standard for diagnosis and management in England. Other parts of the UK publish their own guidance, so check the pathway your local service follows.
European Union and Australia. National health services and regulators set the rules on which hormone products are available and how they are prescribed. The International Menopause Society publishes global recommendations that many national guidelines draw on. In Australia, the Therapeutic Goods Administration regulates products, and a testosterone cream for women has been approved there, which is not the case in the United States.
South Asia and the Middle East. Access to hormone therapy, and the choice of route and progestogen, varies considerably. Local ministries of health and national professional societies set prescribing rules, so confirm what is available in your country. The WHO menopause fact sheet provides a worldwide overview that is useful in any setting.
Frequently asked questions
Do HRT side effects go away?
Many of them do. Breast tenderness, bloating, mild headaches and early spotting often settle within about three months, according to NHS guidance. If they continue, a clinician can change the dose, the route or the type of progestogen. Persistent or severe effects should not simply be endured, and any bleeding that is heavier than usual or unexpected needs to be reported promptly for assessment.
What are the cons of HRT for women?
The main drawbacks are common early side effects, the need for regular review, and serious but uncommon risks such as blood clots, stroke and some cancers. The size of each risk depends on the type and route of hormones, your age, how long you have been menopausal and your health history. For many healthy women with bothersome symptoms who are under 60 or within 10 years of menopause, The Menopause Society concludes that benefits generally outweigh risks.
Can HRT cause weight gain?
Randomized trials have not shown that HRT causes significant weight gain on average. Some women do gain weight during the menopause transition, often because of age, activity levels and sleep, so any change deserves a review. HRT is not a weight-loss treatment and should not be started for that purpose. Physical activity, strength training and good sleep are the approaches the evidence supports most strongly.
Is testosterone added to HRT for menopause?
Testosterone is not a standard part of HRT in the United States, and no testosterone product is FDA-approved for women. The 2019 Global Consensus Position Statement found that the only evidence-based indication is hypoactive sexual desire disorder in postmenopausal women. Side effects can include acne, oily skin and unwanted hair growth. Any use should be discussed with a clinician who can weigh the evidence and monitor you closely.
Are estrogen patch side effects different from tablets?
They can be. Patches and gels more often cause skin redness or itching where they are applied, and a patch may come loose in heat or after bathing. Transdermal estrogen is associated with a lower blood-clot risk than oral estrogen, according to The Menopause Society. Tablets are more likely to cause effects linked to their passage through the liver. If skin irritation is the main problem, a different patch, a gel or a tablet may suit you better.
What are progesterone side effects?
Progestogens can cause bloating, breast tenderness, irritability, low mood and changes in sleep. The effects depend on whether the hormone is a synthetic progestin or micronized progesterone, and on the dose and schedule. Because a progestogen protects the womb lining in women who have a uterus, stopping it without advice is not a safe fix. A clinician can often solve the problem by changing the type or timing of the progestogen.
Does HRT increase breast cancer risk?
Combined HRT, meaning estrogen with a progestogen, is associated with a higher breast cancer risk in the Women's Health Initiative trial. Per 10,000 women-years, the trial found 8 more invasive breast cancers than placebo, in an average group aged 63. Risk depends on age, duration of use and personal history, so ask your clinician how the numbers apply to you.
The bottom line
HRT side effects are common, usually mild and most often start in the first few months. Early effects such as breast tenderness and bloating often settle within about three months. Effects that persist are a reason to review the dose, route or progestogen, not to stop without advice. Serious risks depend on the type and route of hormones, your age and your history. HRT does not cause significant average weight gain. Keep a dated record and bring it to each review. Shebalance can help you log symptoms in one tap a day, and it is also on Google Play. It is free, private and needs no account.
Medical disclaimer
This article is for education only and is not medical advice. It does not diagnose, treat or prevent any condition, and it does not replace the advice of a qualified clinician. Do not start, stop or change any hormone therapy or other medication without speaking to your clinician. If you have urgent symptoms, such as chest pain, sudden shortness of breath, leg swelling or heavy bleeding, contact emergency services.
References
- National Health Service (NHS). Menopause. https://www.nhs.uk/conditions/menopause/
- National Institute for Health and Care Excellence (NICE). Menopause: diagnosis and management, NG23. https://www.nice.org.uk/guidance/ng23
- The Menopause Society. Position statement on hormone therapy, 2022. Menopause. 2022;29(7):767-794. https://menopause.org/ [VERIFY LINK]
- Rossouw JE, Anderson GL, Prentice RL, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA. 2002;288(3):321-333. https://www.whi.org/ [VERIFY LINK]
- Women's Health Initiative. https://www.whi.org/
- U.S. Food and Drug Administration. Announcement on menopausal hormone therapy labeling, November 10, 2025 (press announcement). https://www.fda.gov/ [VERIFY LINK]
- U.S. Food and Drug Administration. Labeling changes for menopausal hormone therapy products, February 12, 2026 (press announcement). https://www.fda.gov/ [VERIFY LINK]
- Davis SR, Baber R, Panay N, et al. Global Consensus Position Statement on the use of testosterone therapy for women. Climacteric. 2019. [VERIFY LINK]
- U.S. Food and Drug Administration. Public meeting on testosterone use in menopausal women, September 17, 2026. https://www.fda.gov/consumers/womens-health-events/fda-public-meeting-testosterone-use-menopausal-women-09172026
- American College of Obstetricians and Gynecologists. Patient FAQs. https://www.acog.org/womens-health/faqs
- National Institute on Aging. Menopause. https://www.nia.nih.gov/health/menopause
- Office on Women's Health. Menopause. https://www.womenshealth.gov/menopause
- World Health Organization. Menopause fact sheet. https://www.who.int/news-room/fact-sheets/detail/menopause
- International Menopause Society. https://www.imsociety.org/
Shebalance
Track PCOS and menopause symptoms privately: one-tap logs, weekly trends and a doctor-ready PDF. Free, no account.